Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
C-reactive protein (CRP) is a risk factor or biomarker for cardiovascular diseases, including hypertension.
|
20157054 |
2010 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
HbA1c is positively associated with CVD such as the carotid and coronary artery atherosclerosis, ischemic heart disease, ischemic stroke and hypertension.HbA1c induces dyslipidemia, hyperhomocysteinemia, and hypertension, and increases C-reactive protein, oxidative stress and blood viscosity that would contribute to the development of cardiovascular diseases.
|
30179123 |
2018 |
Cardiovascular Diseases
|
0.400 |
AlteredExpression
|
group |
BEFREE |
In conclusion, abnormal ABI, GNRI, and CRP levels were closely associated with each other, and the combination of these variables increase their predictive values for the risk of mortality due to CVD and all-cause mortality in HD patients.
|
28430145 |
2017 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
C-reactive protein (CRP) is associated with cardiovascular disease, irrespective of the presence of metabolic syndrome.
|
28885336 |
2017 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
We review here the most recent evidence on mechanisms by which CRP is involved as a causal factor in the precipitation of cardiovascular disease.
|
15529024 |
2004 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
These findings suggest a complex interaction among cholesterol, CRP, and cardiovascular disease in PD patients.
|
22241816 |
2012 |
Cardiovascular Diseases
|
0.400 |
GeneticVariation
|
group |
BEFREE |
We investigated whether the SNP rs9939609 (T/A) of the FTO is associated with risk factors of cardiovascular diseases (CVD), including serum levels of C - reactive protein (CRP), the chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted; CCL5), and serum and lipoprotein lipids in the Finnish Diabetes Prevention Study (DPS).
|
20400278 |
2011 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
Through decreasing NO synthesis, CRP may facilitate the development of diverse cardiovascular diseases.
|
12186793 |
2002 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
Our findings suggest that CRP may link to CVD by other mechanisms than promoting formation and progression of atherosclerotic plaques.
|
28728065 |
2017 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
C-reactive protein (CRP), a biomarker of inflammation, has been associated with increased risk of developing cardiovascular disease.
|
20716378 |
2010 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
Several factors frequently associated with CVD risk in normal aging (elevated CRP, total and LDL cholesterol) showed no difference and are unlikely to influence CVD risk in HGPS.
|
15756215 |
2005 |
Cardiovascular Diseases
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Here, we assessed whether low serum PON1 activity associates with incident cardiovascular disease (CVD) in subjects with high levels of high-density cholesterol (HDL-C) and C-reactive protein (CRP), a marker of low-grade systemic inflammation.
|
31480611 |
2019 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
The independent CRP and sTNF-R1 biomarker associations with CVD deaths were enhanced by a gradient of their dichotomous z-score values in survival models.
|
27782866 |
2017 |
Cardiovascular Diseases
|
0.400 |
GeneticVariation
|
group |
BEFREE |
CRP values were categorized according to the predicted risk of cardiovascular disease (CVD) at hospital admission (acute inflammatory response): 0 to <5 mg/L, 5 to <10 mg/L, 10 to <20 mg/L, and ≥ 20 mg/L; and at 3-month follow-up (low-grade inflammation): 0 to <1 mg/L, 1 to <3 mg/L, and ≥ 3 mg/L.
|
29880326 |
2018 |
Cardiovascular Diseases
|
0.400 |
AlteredExpression
|
group |
BEFREE |
An elevated serum C-reactive protein (CRP) level is a strong marker for future atherosclerotic cardiovascular diseases.
|
15136507 |
2004 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
However, inflammation per se possibly contributes to atherothrombotic and venothrombotic disease, and CRP measurement may be used in risk assessment and treatment monitoring in atherothrombotic cardiovascular disease.
|
19667982 |
2009 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
BMI >45 kg/m<sup>2</sup> was associated with higher prevalence of hypertension, systolic and diastolic blood pressure, C-reactive protein, waist circumference, body fat % and family history of heart diseases, enhancing the risk for the occurrence of cardiovascular diseases.
|
31791637 |
2020 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
We examined the association of baseline plasma CRP with subclinical CVD in women with and without HIV.
|
29438198 |
2018 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
C-reactive protein (CRP) is a marker of inflammation that has been shown to be predictive of cardiovascular diseases in adults.
|
28537577 |
2017 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?
|
23727085 |
2013 |
Cardiovascular Diseases
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Systemic inflammation, measured by C-reactive protein (CRP), is an important risk factor for cardiovascular disease (CVD) and mortality.
|
28811734 |
2017 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
Although these findings need to be confirmed in larger prospective cohorts, CRP may be useful in risk stratifying OSA patients to guide therapy or to identify patients that might be most appropriate for clinical trials of CVD prevention.
|
31089857 |
2019 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
So there is growing evidence that CRP is not only a marker for cardiovascular disease but also might be pathogenic.
|
28883850 |
2017 |
Cardiovascular Diseases
|
0.400 |
AlteredExpression
|
group |
BEFREE |
C reactive protein (CRP) levels are elevated in many diseases, including malignant tumors and cardiovascular disorders.
|
30025407 |
2018 |
Cardiovascular Diseases
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis.
|
27534721 |
2016 |